Author

X.-T. Wang

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:benchmarking· 1 Organism:chicken / avian· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1 Organism:non-human primate· 1

Frequent Co-Authors

A. J. Korman· 1 shared G. Rak· 1 shared J. A. Zorn· 1 shared J. M. Hogan· 1 shared K. Thudium· 1 shared M. Selby· 1 shared P. Strop· 1 shared R. T. Bunch· 1 shared

Activity by Year

2022-2022 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. J. Korman

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Preclinical Characterization of Relatlimab, a Human LAG-3-Blocking Antibody, Alone or in Combination With Nivolumab

K. Thudium, M. Selby, J. A. Zorn, G. Rak, X.-T. Wang, R. T. Bunch, J. M. Hogan, P. Strop, A. J. Korman

This paper characterizes relatlimab, a LAG-3-blocking antibody, showing it enhances anti-tumor activity when combined with nivolumab in preclinical models and is well-tolerated in monkeys.

bioRxiv · Jan 24, 2022Cancer Biology